139 related articles for article (PubMed ID: 3923750)
1. Involvement of complement in atopic dermatitis.
Kapp A; Schöpf E
Acta Derm Venereol Suppl (Stockh); 1985; 114():152-4. PubMed ID: 3923750
[TBL] [Abstract][Full Text] [Related]
2. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
Kapp A; Wokalek H; Schöpf E
Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
[TBL] [Abstract][Full Text] [Related]
3. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
4. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
5. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
6. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
9. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
10. Complement profile in a C1 inhibitor deficient family.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1985 Dec; 113(6):737-43. PubMed ID: 4096884
[TBL] [Abstract][Full Text] [Related]
11. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
12. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
13. Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
Langlois PF; Gawryl MS
Atherosclerosis; 1988 Mar; 70(1-2):95-105. PubMed ID: 3258520
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis.
Hopkins P; Belmont HM; Buyon J; Philips M; Weissmann G; Abramson SB
Arthritis Rheum; 1988 May; 31(5):632-41. PubMed ID: 3259882
[TBL] [Abstract][Full Text] [Related]
15. Complement activation produced by biomaterials.
Chenoweth DE
Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
[TBL] [Abstract][Full Text] [Related]
16. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
17. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
[TBL] [Abstract][Full Text] [Related]
18. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
[TBL] [Abstract][Full Text] [Related]
19. Complement activation during liver transplantation.
Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
[TBL] [Abstract][Full Text] [Related]
20. Altered concentrations of terminal complement complexes, anaphylatoxins, and leukotrienes in the coronary sinus during cardiopulmonary bypass.
Bengtson A; Millocco I; Heideman M; Berggren H
J Cardiothorac Anesth; 1989 Jun; 3(3):305-10. PubMed ID: 2520655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
